Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011 Nov 30;1(4):e125.
doi: 10.4081/cp.2011.e125. eCollection 2011 Sep 28.

Multiple sclerosis in an adrenoleukodystrophy carrier

Affiliations
Case Reports

Multiple sclerosis in an adrenoleukodystrophy carrier

Thomas Jenkins et al. Clin Pract. .

Abstract

X-linked adrenoleukodystrophy (X-ALD) is a rare inherited metabolic disorder, in which accumulation of very long chain fatty acids (VLCFAs) results in damage to the central nervous system. As the disease is X-linked, males are affected severely, but female carriers may also present with neurological symptoms. We report the case of a young adult female, who presented with episodic sensorimotor symptoms. Although she was a heterozygous female carrier of X-ALD, subsequent investigations confirmed a diagnosis of multiple sclerosis (MS). To the best of our knowledge, this is the first reported case of a female X-ALD carrier in which the clinical features were more consistent with co-existent MS than ALD-related pathology. The case serves as a reminder that alternative, more common diagnoses should also be considered in carriers of rare neurological syndromes.

Keywords: adrenoleukodystrophy.; multiple sclerosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Axial T2-weighted and (B) sagittal fluid-attenuated inversion recovery magnetic resonance imaging sequences show periventricular hyperintense lesions in a typical pattern for multiple sclerosis.

References

    1. Moser HW. Clinical and therapeutic aspects of adrenoleukodystrophy and adrenomyeloneuropathy. J Neuropathol Exp Neurol. 1995;54:740–5. - PubMed
    1. Van Geel BM, Assies J, Wanders RJ, Barth PG. X linked adrenoleukodystrophy: clinical presentation, diagnosis and therapy. J Neurol Neurosurg Psychiatry. 1997;63:4–14. - PMC - PubMed
    1. Berger J, Gartner J. X-linked adrenoleukodystrophy: Clinical, biochemical and pathogenetic aspects. Biochim Biophys Acta. 2006;1763:1721–32. - PubMed
    1. Ferrer I, Aubourg P, Pujol A. General aspects and neuropathology of X-linked adrenoleukodystrophy. Brain Pathol. 2010;20:817–30. - PMC - PubMed
    1. Turakhia S, Agarwal A. Adrenoleukodystrophy–Images. Ind J Radiol Imaging. 2005;15:321–23.

Publication types